Injectable Drug Delivery Injections for Self-Administration to Double by 2028, Sales Revenue to Stand at US$ 32.1 Bn; Predicts - Future Market Insights

Wednesday, August 8, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

VALLEY COTTAGE, New York, August 8, 2018 /PRNewswire/ --

Rising prevalence of chronic diseases, technological advancements,

growth of biologics, and demand for self-injecting drugs is likely to augment the global adoption of injectable drug delivery devices and expand at an impressive CAGR of 10.9% during the assessment period of 2018-2026. The global injectable drug delivery
market is likely to stand at a market valuation of US$ 32.1 Bn by 2028, according to a recent market study by Future Market Insights. The long-term outlook on the global injectable drug delivery market remains positive throughout the forecast period owing to its increased adoption among patients with chronic illnesses. In the comprehensive analysis of the global injectable drug delivery market, experts at FMI have studied the various drivers, restraints, opportunities, and trends likely to impact the market in the next 10 years.

     (Logo: https://mma.prnewswire.com/media/677274/Future_Market_Insights_Logo.jpg )

Globally, sales of injectable drug delivery devices will witness robust growth in the U.S, Western Europe, and Asia Pacific, largely owing to FDA approvals for innovative and novel auto-injectors and increasing adoption of injectable drug delivery mechanisms across various applications. Manufacturers operating in the global injectable drug delivery market are in for a plethora of opportunities owing to increased investments in the research and development of injectable drug delivery devices such as disposable and reusable injectors. Manufacturers are also considering setting up regional manufacturing bases to focus on the production of superior grade injectable drug delivery devices to meet rapidly surging end user demand.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-393

Increased Interest in Self-Administrations Giving Way to Novel Injectable Drug Delivery Innovations  

Demand for self-administering injectable syringes has been increasing-significantly cutting on caregiver fees and enhanced development in syringes, cartridges, auto injectors, and pens. Injectable drug delivery devices developers are constantly looking out for more mainstream ways to enhance the patient-injection experience-elevating the growth of disposable injectors.

Although self-administration of medication seems to be convenient, a number of factors such as dosage management, and needle stick injuries can make it difficult. Advancement in technologies address these issues and have popularized the use of injectable drug delivery devices for patient-controlled medication.

Despite the fact that needles remain the primary route for drug delivery, developers are evaluating needle-free systems for specific applications. Manufacturers are making advancement in needle technology, ensuring reduced needle exposure before and after injection.

Needlestick Injuries Prevention Opens up Opportunities for Injectable Drug Delivery Devices Companies  

Devices that can help prevent needlestick injuries are a potential growth market for injectable drug delivery market. As per the guidelines of the Occupational Safety and Health Administration (OSHA), injectable must have safety features that are passive and require no intervention by the user-not compromising on the device safety and effectiveness. Patients using Insulin syringe often report percutaneous needle stick injury caused by the needle tips and can occur while using, handling, disassembling, or disposing needles and syringes. As per CDC, close to 3,85,000 cases of needlestick injuries are reported each year in the U.S. High incidence rate of needle stick injuries persuade health care professionals to use drug delivery devices that reduce such risk and increase patient comfort, thereby, opening up R&D opportunities for developers and manufacturers.

Preview Analysis On Injectable Drug Delivery Market Segmentation By Product Type - Self-Injectors, Needle-free Injectors, Auto-Injectors; Usage - Disposable Injectors, Reusable Injectors: https://www.futuremarketinsights.com/reports/injectable-drug-delivery-market

Forward Market Strategy: TechCos Aim to Improve Compliance, PharmaCos Deliver Human-Centric Injectable 

Medical experts see a growing trend towards connected devices, wherein a device is connected to a smart phone-tracking, monitoring and sending reports to medical practitioners. The connect device would also remind patients about their next injection schedule, thereby improving compliance.  Pharmaceutical companies, injectable drug delivery devices developers, and tech companies are projected to partner in the near future to make connected devices a reality in the global injectable drug delivery market. Additionally, with increasing self-injection and self-administration preference among patients, pharmaceutical companies have begun to shift towards subcutaneous injectable drug delivery injections owing to ease of use, patient comfort, compliance, and adherence.

Key players operating in the global injectable drug delivery market are Amgen, Medtronic Plc, Dexcom, Crossject, Endo International Plc, and Penjet Corporation, Amgen, Antares Pharma, Becton, and Dickinson and Company.

Request Report TOC @ https://www.futuremarketinsights.com/askus/rep-gb-393

More from Healthcare, Pharmaceuticals and Medical devices: 

  • Neonatal Thermoregulation Market Segmentation By Product Type - Warmer,Radiant Warmer,Wall Mount Warmer,Neonatal Incubators,Intensive Care Incubator,Hybrid Incubator,Selective Close Care Incubators,Transport Incubator,Neonatal Cooling Systems; By Modality Type - Open,Closed; By End User Type - Hospitals,Paediatric and Neonatal,Intensive Care Units,Others: https://www.futuremarketinsights.com/reports/neonatal-thermoregulation-market
  • Digital Pathology Market Segmentation By Product Type - Scanners, Software, Services; By End-Users - Hospitals, Diagnostic Labs, Research Centres; By Pathology Screening Services - Chemical Pathology, Haematology, Histopathology, Medical Microbiology: https://www.futuremarketinsights.com/reports/Global-digital-pathology-market
  • Empty Capsule Market Segmentation By Product Type - Gelatin (Hard)-Based Capsules and Vegetarian-Based Capsules; By Raw Material; By Route Of Administration - Oral Administration and Inhalation Administration: https://www.futuremarketinsights.com/reports/empty-capsules-market

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Browse More Healthcare, Pharmaceuticals and Medical devices

Contact Us 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: sales@futuremarketinsights.com Press Office: Press@futuremarketinsights.com

FMI Blog: http://www.fmiblog.com/

Website: http://www.futuremarketinsights.com

SOURCE Future Market Insights



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store